tweetindex

Bristol Myers Squibb

@bmsnews · New York, New York · joined 21 Apr 2009

We work every day to transform patients’ lives through science. See our community guidelines: https://t.co/Qd22DZ1Lv4

151 075Followers
1 027Following
8 968Posts total
167.4KViews on collected posts

Against accounts of the same size

10 posts from the last 90 days, next to the 100K–1M follower range. below its peers on both reach and engagement.

Median views2 188this account4 963median for 100K–1M
Reach, %1.45%this account2.08%median for 100K–1M
Engagement, %0.57%this account1.47%median for 100K–1M
MetricThis accountMedian for 100K–1MRatio
Median views per post2 1884 9630.44×
Reach (views ÷ followers)1.45%2.08%0.70×
Engagement rate0.57%1.47%0.39×

Others in this range →   Compare with another account →   How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

143.6K31 Jul
10.2K10 Aug
45
1.8K12 Aug
6.3K13 Aug
4414 Aug
3517 Aug
1421 Aug
2.6K27 Aug
2.8K29 Aug

Last 10 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.11%31 Jul
0.59%10 Aug
0.00%
0.55%12 Aug
0.62%13 Aug
2.27%14 Aug
0.00%17 Aug
0.00%21 Aug
0.86%27 Aug
0.83%29 Aug

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 1.47%.

What the audience does

Likes70.6%221 in total
Reposts16.9%53 in total
Replies6.7%21 in total
Quotes4.5%14 in total
Bookmarks1.3%4 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

#MEDIA: At the 2026 #ESCCongress, we shared new long-term and real-world data in adults with symptomatic obstructive hypertrophic cardiomyopathy, adding to real-world evidence on long-term outcomes for this patient population: https://t.co/itUPL5CSeE https://t.co/w4mSz3kCzs 2.8K views · 18 likes · 3 reposts · 2 replies 29 Aug 2026 We're investing more than $173 million to expand U.S. radiopharmaceutical manufacturing capacity and help deliver next-generation cancer treatments to patients. Led by @RayzeBio, this investment will support jobs and innovation in Indiana. https://t.co/q41fxnf20x #OneBMS https:// 2.6K views · 19 likes · 3 reposts · 0 replies 27 Aug 2026 @bmsnews @US_FDA #4 https://t.co/ZZ7nJaRaXB 14 views · 0 likes · 0 reposts · 0 replies 21 Aug 2026 @bmsnews @US_FDA Encouraging news for people living with relapsed or refractory multiple myeloma. Every new treatment option expands possibilities and brings us closer to more precise, patient-centered care. #MultipleMyeloma #Cancer #Research 35 views · 0 likes · 0 reposts · 0 replies 17 Aug 2026 @bmsnews @US_FDA This getting serious complicated ….. here is the issue big pharma is designing combinatorial drug in a vacuum of the patients immune and genetic status …..May I make a suggestion to medical establishment, FDA included, to have immune / genetic monitoring work up 44 views · 1 likes · 0 reposts · 0 replies 14 Aug 2026 #MEDIA: @US_FDA granted accelerated approval to our new CELMoD treatment for relapsed or refractory #MultipleMyeloma in adults, introducing a new class of treatment. https://t.co/AjYS3vF6ac https://t.co/Tqf2BELoFy 6.3K views · 26 likes · 7 reposts · 4 replies 13 Aug 2026 For more than 25 years, the BMS Foundation, an independent charitable organization, has been strengthening health systems in Africa to address adult cancers as well as pediatric cancers and blood disorders. Read how our grantees are making an impact: https://t.co/nxEOQSolOI https 1.8K views · 9 likes · 1 reposts · 0 replies 12 Aug 2026 @bmsnews Why???? BMS closed/ sold major US manufacturing sites several years ago. Just bowing down to the current administration. Makes no sense 45 views · 0 likes · 0 reposts · 0 replies 10 Aug 2026 #MEDIA: Today, we announced a $2.3 billion investment to build a new manufacturing campus in Houston, Texas. Read more: https://t.co/8OKBDoewsW https://t.co/Tdt3p7V5s5 10.2K views · 41 likes · 9 reposts · 2 replies 10 Aug 2026 A proposed convergent molecular chain linking senescence, cancer, and chronic infection to a correctable failure of dendritic cell instruction https://t.co/gRXOlq69RV 143.6K views · 107 likes · 30 reposts · 13 replies 31 Jul 2026

Similar accounts